Withdrawal of New Facility Investment Plan Due to Rising Construction Costs, Land Sale to Strengthen Financial Health
-
Withdrawal of new facility investment plan (original investment: 30 billion KRW, equity: approx. 101 billion KRW)
-
Reason: sharp rise in construction costs leading to lower investment efficiency and excessive operating expenses
-
Decision to sell the land to secure spare funds and maximize operational efficiency and financial soundness
-
Correction date: 2026-04-30, original board resolution date: 2023-08-10
-
Original investment period (2023-08-10~2026-06-30) and purpose (new office building, rental income) completely canceled
KOSDAQ Filing Information
-
-
[Correction of Description] Investment in New Facilities, etc.
-
Company: HLB bioStep (278650)
-
Submission: HLB bioStep Co.,Ltd.
-
Under KRX KOSDAQ Market Division
-
-
Shares: 87,161,984
-
Price: 1,272 KRW
-
Market Cap: 110.9 B KRW